CAMBRIDGE MOLECULAR DIAGNOSTICS LTDActive

Company number 09600771Private limited companyIncorporated 2015

Key figures

£2,494,684+8.7%
Net assets 2025
+33.9%
Average annual growth 2019/20–2025
01 m2 m3 m2019/202020/212021/222022/2320242025

CAMBRIDGE MOLECULAR DIAGNOSTICS LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2019/202020/212021/222022/2320242025
Filed accounts2019/20–2025
2020/212021/222022/2320242025
Profit for the year-111,649-119,010-240,808-145,689-171,709
Cash at bank and in hand451,304172,566176,59539,9779,822
Total assets1,272,7311,231,4161,641,3652,652,3843,031,992
Total liabilities656,256733,951785,727357,620537,308
Net assets / total equity616,475497,465855,6382,294,7642,494,684
Average number of employees57866

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CAMBRIDGE MOLECULAR DIAGNOSTICS LTD

Company

CAMBRIDGE MOLECULAR DIAGNOSTICS LTD is a private limited company registered with Companies House under company number 09600771. It was incorporated on 20 May 2015. Its status is active. The registered office is in Cambridge (CB4). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Loss for the year was £171,709. Net assets were £2,494,684, up 8.7% on the previous year. Cash at bank and in hand was £9,822. Total assets were £3,031,992 and total liabilities £537,308. The company had an average of 6 employees. Figures are available for 6 financial years (2019/20–2025).

Control and charges

2 persons with significant control are registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 3 Mar 2027.